Patient and Original Tumor Characteristics (n = 115)
| Characteristic | Value |
| Age (y) | |
| Mean | 65.7 |
| Range | 49–87 |
| PSA level (ng/mL) at MR imaging/11C-choline PET/CT | |
| Mean | 5.26 |
| Range | 0.58–68.3 |
| Median | 2.5 |
| Interval between RP and MR imaging/11C-choline PET/CT (mos) | |
| Mean | 80.8 |
| Range | 4–276 |
| Treatment before MR imaging/11C-choline PET/CT (%) | |
| RP only | 30 (26.1) |
| RP and salvage EBRT | 30 (26.1) |
| RP and ADT | 29 (25.2) |
| RP, salvage EBRT, and ADT | 25 (21.7) |
| RP, salvage cryoablation, and ADT | 1 (0.9) |
| Pathologic stage at surgery (%) | |
| pT2 N0 | 41 (35.7) |
| pT3a N0 | 21 (18.3) |
| pT3b N0 | 21 (18.3) |
| Any T pN1 | 32 (27.8) |
| Positive surgical margin (%) | 52 (45.2) |
| Pathologic Gleason scores at surgery (%) | |
| 2–6 | 10 (8.7) |
| 7 (3 + 4) | 37 (32.2) |
| 7 (4 + 3) | 23 (20.0) |
| 8–10 | 45 (39.1) |
Values in parentheses are percentages.
EBRT = external-beam radiotherapy; ADT = androgen-deprivation therapy.